COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research has published a research update on ad pepper media International N.V., reiterating a BUY rating and decreasing the price target. The update discusses APM's preliminary 2023 figures and the reasons for the decline, as well as the planned acquisition of a majority stake in solute, and the impact of the macroeconomic environment on the market. For more details, visit http://www.more-ir.de/d/28857.pdf -
COMMUNIQUÉ DE PRESSE
GoldenPeaks Capital signs Power Purchase Agreement with Auchan Polska.
GoldenPeaks Capital signs 12-year Power Purchase Agreement (PPA) with Auchan Polska to supply approximately 115 gigawatt hours of renewable electricity annually, aiming to reduce Auchan's carbon footprint in Poland -
COMMUNIQUÉ DE PRESSE
Original-Research: UBM Development AG (von NuWays AG): BUY
UBM Development AG receives building permit for Timber Peak project in Mainz, expected to be completed in Q2‘25e. Company also set to publish FY23 prelims in early March. Analysts maintain buy recommendation with PT of €31.00 based on DDM -
COMMUNIQUÉ DE PRESSE
Original-Research: SMARTBROKER Holding AG (von NuWays AG): BUY
SMARTBROKER Holding AG's latest update report includes declining customer numbers, reduced assets under custody, positive key performance indicators in the media segment, and the departure of the longtime CFO Roland Nicklaus -
COMMUNIQUÉ DE PRESSE
Original-Research: Netfonds AG (von NuWays AG): BUY
Update on Netfonds AG by NuWays AG recommends BUY with a target price of €71.00. Anticipated favorable trends for 2024 include strong dollar, inflows into wealth management, money market fund opportunities, insurance broker market consolidation, and significant cross-selling potential -
COMMUNIQUÉ RÉGLEMENTÉ
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 janvier 2024
Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 janvier 2024 conformément à l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers. Amoéba, acteur du traitement du risque microbiologique dans les secteurs de l’eau, de la protection des plantes et de la santé. Commercialisation des produits dès 2025 -
-
-
